Consequently, we showed the antitumor effects of the combined agents in vivo and identified for the first time the important role of Serpinc1 in lung cancer progression and treatment, including cell proliferation, apoptosis, migration, and invasion possibly via the Pi3K/AKT pathway. Here, SERPINC1 is linked to lung cancer.